TABLE 3.
Druggability screening of the prioritized potential drug targets.
| Protein IDs | Protein names | PDB homologs | % Identity | Query coverage (%) | Q-mean scores | GMQE score | Template vs. Model RMSD (Å) | ERRAT scores | Pocket residues (PockDrug > 0.5) |
| WP_014614444.1 | SUF system NifU family Fe-S cluster assembly protein | 6jzv.1.A | 67.8 | 98 | 0.77 | 0.78 | 2.00 vs. 2.00 | 96.8992 | 16.0 (1.0) |
| WP_015728500.1 | MULTISPECIES: ribonuclease P protein component | 6ov1.2.A | 78.07 | 99 | 0.83 | 0.86 | 1.70 vs. 1.66 | 95.2381 | 17.0 (0.94) |
| WP_198461100.1 | YvcK family protein | 2ppv.1.A | 67.48 | 99 | 0.86 | 0.9 | 2.00 vs. 2.00 | 98.4177 | 19.0 (0.81) |
| WP_014613626.1 | DUF4479 domain-containing protein | 3bu2.1.A | 64.65 | 99 | 0.82 | 0.88 | 2.70 vs. 2.70 | 92.0245 | 20.0 (0.72) |
| WP_063284624.1 | UDP-N-acetylmuramoyl-L-alanyl-D-glutamate–L-lysine ligase | 4c12.1.A | 79.47 | 100 | 0.91 | 0.94 | 1.80 vs. 1.80 | 94.7034 | 30.0 (0.71) |
| WP_014614178.1 | Cell division protein FtsA | 3wqt.1.A | 75.32 | 99 | 0.88 | 0.83 | 2.20 vs. 2.20 | 92.3944 | No Pockets |